← Open Payments lookup

NIPAPORN BUADAENG: Open Payments

NPI 1366939019 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,413 in 60 payments from 25 companies in 2025. Trend: 2023 $558 · 2024 $951 · 2025 $1,413

Food & beverage: $1,413
CompanyPaymentsAmount
Abbott Laboratories4$180
Amgen Inc.5$126
PFIZER INC.6$123
Axsome Therapeutics, Inc.4$107
Otsuka America Pharmaceutical, Inc.4$107
ABBVIE INC.5$100
Takeda Pharmaceuticals U.S.A., Inc.3$75
Almatica Pharma LLC3$70
Alkermes, Inc.2$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52

Products named: FREESTYLE LIBRE 3, REXULTI, TRINTELLIX, OTEZLA, LOREEV XR, ELIQUIS, Auvelity, ARISTADA.

Industry payments across NV — which companies pay providers there.